These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 12003803)
1. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Imamura G; Bertelli AA; Bertelli A; Otani H; Maulik N; Das DK Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H1996-2003. PubMed ID: 12003803 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological preconditioning with resveratrol: role of nitric oxide. Hattori R; Otani H; Maulik N; Das DK Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H1988-95. PubMed ID: 12003802 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of ischemia/reperfusion injury in rats by the anti-inflammatory action of resveratrol. Das S; Falchi M; Bertelli A; Maulik N; Das DK Arzneimittelforschung; 2006; 56(10):700-6. PubMed ID: 17225566 [TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice. Jiang X; Shi E; Nakajima Y; Sato S Anesthesiology; 2004 Jul; 101(1):82-8. PubMed ID: 15220775 [TBL] [Abstract][Full Text] [Related]
5. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Das S; Alagappan VK; Bagchi D; Sharma HS; Maulik N; Das DK Vascul Pharmacol; 2005; 42(5-6):281-9. PubMed ID: 15905131 [TBL] [Abstract][Full Text] [Related]
7. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433 [TBL] [Abstract][Full Text] [Related]
8. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS. Zhao TC; Taher MM; Valerie KC; Kukreja RC Circ Res; 2001 Nov; 89(10):915-22. PubMed ID: 11701619 [TBL] [Abstract][Full Text] [Related]
9. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase]. Shi EY; Jiang XJ; Bai H; Nakajima Y Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS? Bell RM; Smith CC; Yellon DM Cardiovasc Res; 2002 Feb; 53(2):405-13. PubMed ID: 11827691 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294 [TBL] [Abstract][Full Text] [Related]
12. Cardioprotective actions of endogenous IL-10 are independent of iNOS. Jones SP; Trocha SD; Lefer DJ Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H48-52. PubMed ID: 11406467 [TBL] [Abstract][Full Text] [Related]
13. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Xi L; Salloum F; Tekin D; Jarrett NC; Kukreja RC Am J Physiol; 1999 Dec; 277(6):H2418-24. PubMed ID: 10600864 [TBL] [Abstract][Full Text] [Related]
14. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Ray PS; Maulik G; Cordis GA; Bertelli AA; Bertelli A; Das DK Free Radic Biol Med; 1999 Jul; 27(1-2):160-9. PubMed ID: 10443932 [TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. Chander V; Chopra K J Vasc Surg; 2005 Dec; 42(6):1198-205. PubMed ID: 16376214 [TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury. Ding HL; Zhu HF; Dong JW; Zhu WZ; Yang WW; Yang HT; Zhou ZN Acta Pharmacol Sin; 2005 Mar; 26(3):315-22. PubMed ID: 15715927 [TBL] [Abstract][Full Text] [Related]
17. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase. Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191 [TBL] [Abstract][Full Text] [Related]
18. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction. Xi L; Kukreja RC Toxicology; 2000 Nov; 155(1-3):37-44. PubMed ID: 11154795 [TBL] [Abstract][Full Text] [Related]
19. VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium. Thirunavukkarasu M; Juhasz B; Zhan L; Menon VP; Tosaki A; Otani H; Maulik N Free Radic Biol Med; 2007 May; 42(10):1487-95. PubMed ID: 17448895 [TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Yoshida T; Maulik N; Engelman RM; Ho YS; Das DK Circ Res; 2000 Feb; 86(3):264-9. PubMed ID: 10679476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]